Efficacy and safety of alfacalcidol in Chinese postmenopausal women aged over 65 with osteoporosis or osteopenia: An open label, non-comparative, post marketing observational study.

[ 16 – 22 ] In this study, we showed that BMDs at all sites had no significant changes after alfacalcidol treatment, only the lumbar L1-4 BMD showing an increasing trend from 0.951 ± 0.132 g/cm 2 to 0.957 ± 0.143 g/cm 2 .

also in 63,971 other papers